These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7026690)
1. A simple method for the quantitation of specific cytotoxic precursors to syngeneic tumors. Teh HS; Kwong L; Yu M; Kilburn DG J Immunol Methods; 1981; 46(1):97-111. PubMed ID: 7026690 [No Abstract] [Full Text] [Related]
2. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes. Hale AH; Paulus LK Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696 [No Abstract] [Full Text] [Related]
3. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo. Green WR J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986 [No Abstract] [Full Text] [Related]
4. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. Green WR; Nowinski RC; Henney CS J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211 [No Abstract] [Full Text] [Related]
5. Stimulatory cells in the generation of T-cell-mediated cytotoxicity: potent stimulating activity of a small radioresistant spleen cells population (RSCs). Reme T; D'Angeac AD; Radal M; Serrou B Cell Immunol; 1981 Sep; 63(2):335-48. PubMed ID: 6974053 [No Abstract] [Full Text] [Related]
6. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia. Schmidt W; Festenstein H; Atfield G Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291 [No Abstract] [Full Text] [Related]
7. The biologic effects of allogeneic factor on T lymphocytes. II. The specificity of AEF-induced cytotoxic T lymphocytes. Altman A; Cardenas JM; Bechtold TE; Katz DH J Immunol; 1980 Jan; 124(1):114-20. PubMed ID: 6153087 [No Abstract] [Full Text] [Related]
9. Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens. Cerottini JC; MacDonald HR J Immunol; 1981 Feb; 126(2):490-6. PubMed ID: 6450245 [No Abstract] [Full Text] [Related]
10. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells. Paciucci PA; Macphail S; Zarling JM; Bach FH J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969 [No Abstract] [Full Text] [Related]
11. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis. Grönberg A; Kiessling R; Eriksson E; Hansson M J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295 [No Abstract] [Full Text] [Related]
12. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes. Plata F; Tilkin AF; Lévy JP; Lilly F J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533 [TBL] [Abstract][Full Text] [Related]
13. The relationship of alloreactivity to syngeneic tumor immunity. Greene MI; Perry LL Transplant Proc; 1980 Mar; 12(1):80-6. PubMed ID: 6154362 [No Abstract] [Full Text] [Related]
14. Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2. Ng AK; McIntire R; Holden HT; Herberman RB J Immunol; 1978 Sep; 121(3):856-62. PubMed ID: 690439 [No Abstract] [Full Text] [Related]
15. Secondary induction of cytotoxic T lymphocytes with solubilized syngeneic tumor cell plasma membranes. Alaba O; Law LW J Exp Med; 1978 Nov; 148(5):1435-9. PubMed ID: 309916 [TBL] [Abstract][Full Text] [Related]
16. Virus-associated surface antigens on L cells and Moloney lymphoma cells. Fenyö EM; Grundner G; Klein E J Natl Cancer Inst; 1974 Mar; 52(3):743-51. PubMed ID: 4133193 [No Abstract] [Full Text] [Related]
17. Immunological mechanisms in the pathogenesis of virus-induced murine leukemia. II. Characterization of autoreactive thymocytes. Proffitt MR; Hirsch MS; McKenzie IF; Gheridian B; Black PH Int J Cancer; 1975 Feb; 15(2):230-40. PubMed ID: 47845 [TBL] [Abstract][Full Text] [Related]
18. The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition. Perry LL; Greene MI J Immunol; 1980 Aug; 125(2):738-48. PubMed ID: 6967088 [No Abstract] [Full Text] [Related]
19. Nature and complexity of the FMR antigenic system. Bismuth A; Kremsdorf D; Debré P; Levy JP Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553 [No Abstract] [Full Text] [Related]
20. Lymphocyte-target cell conjugation: membrane receptors for alloantigens. Berke G Adv Exp Med Biol; 1976; 66():483-7. PubMed ID: 1083650 [No Abstract] [Full Text] [Related] [Next] [New Search]